MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$11,343K
Income from transition
services agreements
$1,192K
Net loss
-$134,044K
Total other income
(expense), net
$11,775K
Change in fair value of
participation right liability
$725K
Other income
(expense)
-$35K
Loss from operations
-$145,819K
Total operating
expenses
$145,819K
Research and development
$121,199K
General and
administrative
$24,620K
Back
Back
Income Statement
source: myfinsight.com
BridgeBio Oncology Therapeutics, Inc. (BBOT)
BridgeBio Oncology Therapeutics, Inc. (BBOT)